High-throughput screening method for intergrin antagonist...

Chemistry: molecular biology and microbiology – Apparatus – Including measuring or testing

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07604982

ABSTRACT:
The present invention relates to the screening method of antagonistic material of integrin using the protein chip and useful peptides screened thereby. The protein chip used in the present invention is unique substrate coated with new material, calixarene derivative, which can keep uniform and high activities of proteins. Integrin receptor protein is arrayed high densely on the chip, and materials (protein, peptide, small molecules and so on) specifically inhibiting the binding of ligand can be screened therewith. The integrins used in the present invention are integrin av f3 3 and integrin a1, b j3 3, and new antagonistic peptides screened from peptide library have high binding affinity.

REFERENCES:
patent: 6218136 (2001-04-01), Kumar et al.
patent: 6617114 (2003-09-01), Fowlkes et al.
patent: 6801677 (2004-10-01), Grace et al.
patent: 6986992 (2006-01-01), Chui et al.
patent: 7105508 (2006-09-01), Kling et al.
patent: 2002/0102617 (2002-08-01), MacBeath et al.
patent: 2004-512497 (2004-04-01), None
International Search Report; Date of Completion Mar. 22, 2005; pp. 3; International Application No. PCT/KR2004/003086.
Dubree, Nathan J.P. et al., “Selective α4β7 Integrin Antagonists and Their Potential as Antiflammatory Agents”,J. Med. Chem., vol. 45:3451-3457 (Aug. 2002).
Hessel, Birgit et al., “Primary Structure of Human Fibrinogen and Fibrin, Structural Studies on NH2-terminal Part of BβChain”,Eur. J. Biochem. 98, 521-534 (1979).
Koivunen, Erkki et al., “Inhibition of β2Integrin-mediated Leukocyte Cell Adhesion by Leucine-Leucine-Glycine Motif-containing Peptides”,The Journal of Cell Biology, vol. 153:905-916 (May 28, 2001).
Kornblihtt, Alberto R. et al., “Human Fibronectin: Cell Specific Alternative mRNA splicing Generates Polypeptide Chains Differing in the Number of Internal Repeats”,Nucleic Acids Research, vol. 12(14): 5853-68; (Jul. 25, 1984).
Lee, Yoonsuk et al., “ProteoChip: A Highly Sensitive Protein Microarray Prepared by a Novel Method of Protein Immobilization for Application of Protein-protein Interaction Studies”,Proteomics3:2289-2304 (2003).
Soininen, Raija, et al., “Complete Primary Structure of the αI-Chain of Human Basement Membrane (type IV) collagen”,FEBS Letters, vol. 225 (1,2):188-194 1987).
Suzuki, Shintaro et al., “Complete Amino Acid Sequence of Human Vitronectin Deduced from cDNA. Similarity of Cell Attachment Sites in Vitronectin and Fibronectin”,The EMBO Journal, vol. 4(10):2519-2524, (1985).
Tarui, Takehiko et al., “Plasmin-induced Migration of Endothelial Cells, A Potential Target for the Anti-Angiogenic Action of Angiostatin”,The Journal of Biological Chemistry, vol. 277(37):33564-33570 (2002).
Titani, Koiti et al., “Amino Acid Sequence of Human von Willebrand Factor”,Biochemistry, vol. 25: 3171-3184 (1986).
Lee et al., “Proteochip: A Highly Sensitive Protein Microarray Prepared by a Novel Method of Protein Immobilization for Application of Protein-Protein Interaction Studies”, Proteomics, vol. 3, 2003. pp. 2289-2304.
Notice of Preliminary Rejection for related Japanese patent application No. 2006-535278.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

High-throughput screening method for intergrin antagonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High-throughput screening method for intergrin antagonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High-throughput screening method for intergrin antagonist... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4083216

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.